共 50 条
- [31] Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients Journal of Clinical Immunology, 2023, 43 : 2091 - 2103
- [36] Common variable immunodeficiency (CVID) with granulomatous interstitial lung disease (GLILD) and SARS COVID-19 infection: case report and review of literature ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2021, 17 (01):
- [37] Common variable immunodeficiency (CVID) with granulomatous interstitial lung disease (GLILD) and SARS COVID-19 infection: case report and review of literature Allergy, Asthma & Clinical Immunology, 17